Choline phospholipid metabolites of human vascular endothelial cells altered by cyclooxygenase inhibition, growth factor depletion, and paracrine factors secreted by cancer cells

Molecular Imaging

Volumn 2, Issue 2, 2003, Pages 124-130

  Mori, Noriko ^a   Natarajan, Kshama ^a   Chacko, V P ^a   Artemov, Dmitri ^a   Bhujwalla, Zaver M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Choline metabolites; Conditioned medium; Cyclooxygenase inhibition; Endothelial cells; NMR spectroscopy

Indexed keywords

CELLS; ENZYME INHIBITION; GROWTH KINETICS; MAGNETIC RESONANCE IMAGING; METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOLOGY; PHOSPHOLIPIDS; TUMORS;

CANCER CELLS; CHOLINE PHOSPHOLIPID METABOLITES; CYCLOOXYGENASE INHIBITION; GROWTH FACTOR DEPLETION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMAN VASCULAR ENDOTHELIAL CELLS; PARACRINE FACTORS; PHOSPHOCHOLINE;

MEDICAL IMAGING;

ANTIINFLAMMATORY AGENT; CHOLINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GROWTH PROMOTOR; INDOMETACIN; ISOENZYME; MEMBRANE PROTEIN; PHOSPHOLIPID; PROSTAGLANDIN SYNTHASE; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL CULTURE; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; HUMAN; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELLS, CULTURED; CHOLINE; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIUM, VASCULAR; GROWTH SUBSTANCES; HUMANS; INDOMETHACIN; ISOENZYMES; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE PROTEINS; PHENOTYPE; PHOSPHOLIPIDS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR CELLS, CULTURED;

EID: 0041473368     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/153535003322332000     Document Type: Article

References (26)

1. Smalley WE, DuBois RN (1997). Colorectal cancer and non-steroidal anti-inflammatory drugs. Adv Pharmacol. 39:1-20.
2. Tsuji S, Tsujii M, Kawano S, Hori M (2001). Cyclooxygenase-2 upregulation as a perigenetic change in carcinogenesis. J Exp Clin Cancer Res. 20:117-129.
3. Howe LR, Subbaramaiah K, Brown AM, Dannenberg AJ (2001). Cyclooxygenase-2: A target for the prevention and treatment of breast cancer. Endocr Relat Cancer. 8:97-114.
4. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN (1998). Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 93:705-716.
5. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS (1999). Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med. 5:1418-1423.
6. Aboagye EO, Bhujwalla ZM (1999). Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res. 59:80-84.
7. Natarajan K, Mori N, Artemov D, Aboagye EO, Chacko VP, Bhujwalla ZM (2000). Phospholipid profiles of invasive human breast cancer cells are altered toward a less invasive phospholipid profile by the anti-inflammatory agent indomethacin. Adv Enzyme Regul. 40:271-284.
8. Culic O, Gruwel ML, Schrader J (1997). Energy turnover of vascular endothelial cells. Am J Physiol. 273:C205-C213.
9. Culic O, Decking UK, Schrader J (1999). Metabolic adaptation of endothelial cells to substrate deprivation. Am J Physiol. 276:C1061-C1068.
10. Decking UK, Alves C, Wallimann T, Wyss M, Schrader J (2001). Functional aspects of creatine kinase isoenzymes in endothelial cells. Am J Physiol Cell Physiol. 281:C320-C328.
11. Merchant TE, Lass JH, Roat MI, Skelnik DL, Glonek T (1990). P-31 NMR analysis of phospholipids from cultured human corneal epithelial, fibroblast and endothelial cells. Curr Eye Res. 9, 1167-1176.
12. Pigueras B, Autran B, Debre P, Gorochov G (1996). Detection of apoptosis at the single-cell level by direct incorporation of fluorescein-dUTP in DNA strand breaks. BioTechniques. 20:634-640.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the folin phenol reagent. J Biol Chem. 193:265-275.
14. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
15. Towbin H, Staehelin T, Gordon J (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA. 76:4350-4354.
16. Bhujwalla ZM, Artemov D, Natarajan K, Ackerstaff E, Solaiyappan M (2001). Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia. 3:143-153.
17. Adebodun F, Post JF (1994). 31P NMR characterization of cellular metabolism during dexamethasone induced apoptosis in human leukemic cell lines. J Cell Physiol. 158:180-186.
18. Adebodun F (1999). Phospholipid metabolism and resistance to glucocorticoid-induced apoptosis in a human leukemic cell line: A 31P-NMR study using a phosphonium analog of choline. Cancer Lett. 140:189-194.
19. Podo F (1999). Tumour phospholipid metabolism. NMR Biomed. 12:413-439.
20. Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM (2001). Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res. 61:3599-3603.
21. Caughey GE, Cleland LG, Penglis PS, Gamble JR, James MJ (2001). Roles of cyclooxygenase (cox)-1 and cox-2 in prostanoid production by human endothelial cells: Selective upregulation of prostacyclin synthesis by cox-2. J Immunol. 167:2831-2838.
22. Warden CH, Friedkin M (1985). Regulation of choline kinase activity and phosphatidylcholine biosynthesis by mitogenic growth factors in 3T3 fibroblasts. J Biol Chem. 260:6006-6011.
23. Tadokoro K, Ishidate K, Nakazawa Y (1985). Evidence for the existence of isozymes of choline kinase and their selective induction in 3-methylcholanthrene- or carbon tetrachloride-treated rat liver. Biochim Biophys Acta. 835:501-513.
24. Hernandez-Alcoceba R, Fernandez F, Lacal JC (1999). In vivo antitumor activity of choline kinase inhibitors: A novel target for anticancer drug discovery. Cancer Res. 59:3112-3118.
25. Ramirez de Molina A, Rodriguez-Gonzalez A, Penalva V, Lucas L, Lacal JC (2001). Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells. Biochem Biophys Res Commun. 285:873-879.
26. Chung T, Huang JS, Mukherjee JJ, Crilly KS, Kiss Z (2000). Expression of human choline kinase in NIH 3T3 fibroblasts increases the mitogenic potential of insulin and insulin-like growth factor I. Cell Signal. 12:279-288.